Acceleron Pharma (XLRN) Announces Quarterly Results
Acceleron Pharma (NASDAQ:XLRN) issued its quarterly earnings data on Wednesday. The company reported ($0.54) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.55) by $0.01, Stock Ratings Network reports.
Shares of Acceleron Pharma (NASDAQ:XLRN) opened at 28.43 on Wednesday. Acceleron Pharma has a 52-week low of $16.78 and a 52-week high of $57.89. The stock has a 50-day moving average of $30.02 and a 200-day moving average of $36.18. The company’s market cap is $894.3 million.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.